AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

WW · NASDAQ · Personal Products & Services

WeightWatchers

Combines digital, workshop, and clinical weight-management subscriptions.

$16.40

After-hours close+0.19 (+1.17%)

At close$16.21(−1.04%)

Something off on this page? Send us feedback.

Profile

WW International, Inc.WWConsumer Discretionary

Offers Behavioral subscriptions built around digital tools and optional workshops, alongside Clinical subscriptions that add WeightWatchers Clinic. The model combines community support with a U.S. clinical pathway for eligible members.

Behavioral subscriptions pair WeightWatchers’ digital program with an optional unlimited-workshops add-on. The model extends the brand’s longstanding use of coaches and community support for behavior change.

Clinical subscriptions combine WeightWatchers Clinic with the digital program and unlimited workshops. Clinically eligible members can access clinicians who may prescribe weight-management medication and help with medication management and insurance coordination.

The U.S.-based Clinical pathway puts the business at the intersection of healthcare and technology. Its delivery depends on digital subscriptions, workshops and coaches, clinician access, and regulatory conditions around telehealth and weight-loss medication.

Company facts

CEOFelicia DellaFortuna and Jonathan Volkmann (Interim Office of the CEO)

ListedJul 3, 2025

ExchangeNASDAQ

HeadquartersNew York, NY

CountryUnited States

Employees3,500

CIK0000105319

ISINUS98262P2002

Key statistics

Market cap$162.0M

EPS (ttm)−$10.00

P/E (ttm)−1.62

ROE-33.8%

P/B0.5813

P/S0.2394

Dividend yield—

Beta2.43vs XLY 0.03

Year to date −48.4% · Average volume (30d) 208.0K

Analysts

Price target, next 12 months$20.00+23.5%Median of 24 analysts · vs the Aug 28 close

ConsensusHold9 of 24 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $16.20

High$20.00+23.5%

Median$20.00+23.5%

Low$20.00+23.5%

12 months agoNowIn 12 months

Latest analyst notes

Date	Firm	Action	Prior target	Target
May 8, 2026	Morgan Stanley	Target	$1.25	$20
Jan 15, 2026	UBS	Target		$34.50

Earnings

EPS

Estimate$0.52

ReportedDue Nov 5, 2026

Revenue

Estimate$152.0M

ReportedDue Nov 5, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 5, 2026Q2 FY26	$0.48	$1.41	+193.8%	$159.1M	$162.3M	+2.0%	+9.54%
Jun 15, 2026Q1 FY26	−$2.16	−$5.20	−140.7%	$158.5M	$168.3M	+6.1%	+0.85%
May 7, 2026Q1 FY26	−$2.45	−$5.20	−112.5%	$158.5M	$168.3M	+6.1%	+11.23%
Nov 6, 2025Q3 FY25	−$0.14	−$0.44	−214.3%	$149.8M	$170.9M	+14.1%	−5.50%

View details

Financial highlights

	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue	$186.6M	$177.0M	$184.3M	$162.8M	$168.3M	$161.4M
Gross profit	$132.9M	$130.5M	$133.0M	$114.1M	$97.8M	$114.1M
Operating income	−$20.2M	$41.4M	$10.6M	−$12.9M	−$29.6M	$9.5M
Net income	−$72.6M	$1.19B	−$56.3M	−$5.8M	−$52.0M	$14.1M
Diluted EPS	−$84.75	$1,366.26	−$5.63	−$0.58	−$5.20	$1.41
Gross margin	71.2%	73.7%	72.2%	70.1%	58.1%	70.7%
Operating margin	-10.8%	23.4%	5.8%	-7.9%	-17.6%	5.9%

Fiscal years (4-quarter sums)FY21 $1.21B · FY22 $1.04B · FY23 $889.6M · FY24 $785.9M · FY25 $710.6M

Revenue by product · Q2 FY26

Subscription$161.4M · 99%

Other$932.0K · 1%

Revenue by geography · Q4 FY25

All Other Segments$56.1M · 100%

Balance sheet, Jun 30, 2026Cash & short-term investments $101.5M · Total debt $426.3M · Total assets $840.4M · Shareholders' equity $278.7M

Dividends

No dividends on record.

Ownership

Institutions 72.03%7.20M sharesInsiders 0.97%96.8K sharesOther 27.00%2.70M shares

Shares outstanding 10.00M · Float 8.93M · 89.3% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
Cooper Creek Partners Management LLC	975.4K	9.76%	13F	May 15, 2026
Galloway Capital Partners, LLC	841.7K	8.42%	13D	May 13, 2026
Fund 1 Investments, LLC	779.6K	7.80%	13G	May 15, 2026
Aristeia Capital, L.L.C.	748.5K	7.49%	13G	May 14, 2026
Millennium Management LLC	648.4K	6.48%	13F	May 15, 2026

Insider tradesForm 4

Date	Insider	Role	Shares	Avg price
Aug 18, 2026	Nikolaj H. Sjoqvist	director	+7,235	$13.84
May 22, 2026	Eugene I. Davis	director	+10,000	$12.63
May 26, 2026	Eugene I. Davis	director	+1,648	$13.48
May 27, 2026	Eugene I. Davis	director	+10,000	$14.73
May 22, 2026	Felicia DellaFortuna	officer: CFO & Member, IOCE	+1,500	$12.68